Tuberculosis and HIV co-infection - Test2 - elhamkhani - TriplyDB

Tuberculosis and HIV co-infection

Tuberculosis and HIV co-infection

http://www.wikidata.org/entity/Q21131403

about

HIV-Associated TB Syndemic: A Growing Clinical Challenge Worldwide Vitamin D Receptor Gene FokI Polymorphism Contributes to Increasing the Risk of Tuberculosis: An Update Meta-Analysis The re-emergency and persistence of vaccine preventable diseases Modelling the course of an HIV infection: insights from ecology and evolution Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium Targeting Mycobacterium tuberculosis nucleoid-associated protein HU with structure-based inhibitors Prisoners co-infected with tuberculosis and HIV: a systematic review The potential impact of coinfection on antimicrobial chemotherapy and drug resistance Mechanistic insights on immunosenescence and chronic immune activation in HIV-tuberculosis co-infection Validation of biomarkers for distinguishing Mycobacterium tuberculosis from non-tuberculous mycobacteria using gas chromatography-mass spectrometry and chemometrics Discordance in CD4+T-cell levels and viral loads with co-occurrence of elevated peripheral TNF-α and IL-4 in newly diagnosed HIV-TB co-infected cases Mapping of Mycobacterium tuberculosis Complex Genetic Diversity Profiles in Tanzania and Other African Countries Advances in biosensing strategies for HIV-1 detection, diagnosis, and therapeutic monitoring.The biology of mycobacterium tuberculosis infection.Uncovering New Pathogen-Host Protein-Protein Interactions by Pairwise Structure Similarity.Intense co-circulation of non-influenza respiratory viruses during the first wave of pandemic influenza pH1N1/2009: a cohort study in Reunion Island.Factors associated with adherence to treatment with isoniazid for the prevention of tuberculosis amongst people living with HIV/AIDS: a systematic review of qualitative data.Immune subversion by Mycobacterium tuberculosis through CCR5 mediated signaling: involvement of IL-10 Cutting edge: control of Mycobacterium tuberculosis infection by a subset of lung parenchyma-homing CD4 T cells Glycoproteomic analysis identifies human glycoproteins secreted from HIV latently infected T cells and reveals their presence in HIV+ plasma Functional, thermodynamics, structural and biological studies of in silico-identified inhibitors of Mycobacterium tuberculosis enoyl-ACP(CoA) reductase enzyme.Expansion of CD25-Negative Forkhead Box P3-Positive T Cells during HIV and Mycobacterium tuberculosis Infection The human antibody response to the surface of Mycobacterium tuberculosis.Outcome of tuberculosis treatment and its predictors among HIV infected patients in southwest Ethiopia.Factors associated with tuberculosis by HIV status in the Brazilian national surveillance system: a cross sectional study.Manipulation of the mononuclear phagocyte system by Mycobacterium tuberculosis.A derived network-based interferon-related signature of human macrophages responding to Mycobacterium tuberculosis Survival rates of human immunodeficiency virus and tuberculosis co-infected patients.HIV-prevalence in tuberculosis patients in Germany, 2002-2009: an estimation based on HIV and tuberculosis surveillance data.Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes.Macrophage Resistance to HIV-1 Infection Is Enhanced by the Neuropeptides VIP and PACAP.Modeling tuberculosis in nonhuman primates.Predictors of death during tuberculosis treatment in TB/HIV co-infected patients in Malaysia.Measuring glutathione redox potential of HIV-1-infected macrophages.Extrapulmonary tuberculosis: Mycobacterium tuberculosis strains and host risk factors in a large urban setting in Brazil Activation associated ERK1/2 signaling impairments in CD8+ T cells co-localize with blunted polyclonal and HIV-1 specific effector functions in early untreated HIV-1 infection.Copy number variation of Fc gamma receptor genes in HIV-infected and HIV-tuberculosis co-infected individuals in sub-Saharan Africa A novel molecule with notable activity against multi-drug resistant tuberculosis.Biarylmethoxy Nicotinamides As Novel and Specific Inhibitors of Mycobacterium tuberculosis.The demographic determinants of human microbiome health

P2860

Q26771348-FED95A79-55D6-4074-B490-0A6D73D6CDFA Q26771966-2D222333-652F-466B-940E-C65D9DE90B85 Q26796600-9C65A85F-B57D-44AC-A589-133F5C367512 Q26853307-356A2C5E-549E-46D4-9FEF-29E4894B5B41 Q26865560-D73435C5-B1ED-416E-8264-1C272F92D59D Q27690716-2F7F97C9-468C-414D-861C-68A6BC6D69D1 Q28080180-AEBED011-F175-4AD2-9C03-9EB2CB322C98 Q28081282-9A88E1E9-EBD8-4701-81F8-63E049D773DB Q28081838-0C0747BA-DFBE-4E13-9CC9-6A09E302076E Q28534508-5D59AB2E-5EF6-42B5-93C4-926E47FBFE71 Q28535056-03094B57-97E0-4D18-BB29-7FE0473E968C Q28603212-3EFF3178-8486-48FA-993E-60CF7EEF9FEF Q30249830-3F8E1068-FBB8-43BA-A67C-5E4B891069DD Q30357155-E2E99627-99D2-4E8C-85AE-773F506EAE2D Q30383768-2B24A1E3-EA8E-4B13-8FBF-E70F5638F9AE Q30421336-6315D79A-DF6F-412C-9C63-27B59FF7FAC9 Q30749203-65711A58-B36E-4080-B406-0EB284171B51 Q31155201-6412FCA2-CA57-43BD-91A4-7AE0BD35E053 Q33566339-ACBB33E6-65F7-46F0-9503-871253288878 Q33589518-3BE7C6AB-09F6-43D9-9C94-1C5C2C069D7A Q33594281-4FC5F798-B5AB-46D6-8FDE-2B75AC5140F3 Q33650173-4A14A80F-9FBE-4BBB-B27E-9273013CBE88 Q33740190-84A035F0-A406-40C9-8917-E25F3F1DA044 Q33806776-D8648F04-E8C4-4719-B917-F6C52682E1AD Q34006803-0BC8CC53-79D2-4748-A95E-5476FB2B671E Q34400291-F8458C38-89A1-4472-9C14-A0F365CE684D Q34406300-58C0363A-FA9C-4B45-9734-3289A6E7659D Q34443505-E2B5F6BA-E822-4495-B65E-0423D68C03FA Q34474070-31AA69A3-381E-4B5E-9BE8-B5364B2E3C85 Q34512904-273C6C44-EAD9-49A3-9248-77E7E2B5F561 Q34789781-BD58E35F-53AE-4E74-9E50-2AB028DD2024 Q34930509-F9A89BAD-4607-49FC-9359-47DC2E2B1C15 Q34951938-4DCD947A-05E5-4821-BEF2-87BBCD8F3F94 Q34958392-9016966A-FF15-4AFA-A46F-A0A89F47550E Q35008956-D84BF1BE-A91D-4932-A62F-D4C5F6DE3DAD Q35021753-8B4B1B62-A23C-4201-B2B0-B2315CEA3EAD Q35046564-BBF1EE77-742B-4C51-BDA9-268B88C69462 Q35143013-01A327CA-DB27-4E68-8005-7B2FDC99D642 Q35181961-1C474B91-BCC2-4D72-A3ED-DD2000857039 Q35186525-FC3E8E4E-6967-4020-9962-7D4ECB6C002B

P2860

Tuberculosis and HIV co-infection

http://www.wikidata.org/entity/Q21131403

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Tuberculosis and HIV co-infection

@ast

Tuberculosis and HIV co-infection

@en

Tuberculosis and HIV co-infection

@en-gb

Tuberculosis and HIV co-infection

@nl

type

label

Tuberculosis and HIV co-infection

@ast

Tuberculosis and HIV co-infection

@en

Tuberculosis and HIV co-infection

@en-gb

Tuberculosis and HIV co-infection

@nl

prefLabel

Tuberculosis and HIV co-infection

@ast

Tuberculosis and HIV co-infection

@en

Tuberculosis and HIV co-infection

@en-gb

Tuberculosis and HIV co-infection

@nl

P1433

Q21131403-210E9CAC-F54E-47C4-B638-961E9112C289

P1476

Q21131403-E8953B85-42ED-445D-8DC8-F2FABE8F66B2

P2093

Q21131403-E79AB718-FBC4-4E30-AA64-A251849D46C8

P275

Q21131403-F65B3ABC-C46A-4508-9296-2AFE31E588C8

P2860

Q21131403-04FEC524-F661-42E8-BB0C-A0012C4095E3

Q21131403-055B287B-CC3B-4358-819A-36EC6F6E8FFD

Q21131403-0570B2BB-7747-4199-80CE-118BB51EDBB6

Q21131403-0635969B-2740-4B24-B1BF-F97B9363B448

Q21131403-09DF4DFF-792A-45AB-9A4C-9DA0ECFE99DA

Q21131403-0D3DD158-A75F-4116-8F62-02F007BE1D1A

Q21131403-0E287E3C-992A-4009-A6F8-0E3A1B3A3885

Q21131403-122412DE-8DEB-450C-BF3E-07E056B2DC5D

Q21131403-13D9371C-09B5-406D-97E8-9F53AECB98A8

Q21131403-17EEBA6C-A083-49F7-A10E-06AE670294DE

P304

Q21131403-CB089CAA-9C73-43E9-BE83-3E15C0841FBA

P31

Q21131403-8C80E514-FED1-432B-A3B1-DA55C8D7A9D7

P3181

Q21131403-7D6DEF43-B5D1-4122-B0D5-0AC1809BF9DD

P356

Q21131403-B3B899AE-4461-4185-95D4-67C9CB1C76A5

P407

Q21131403-99304932-A179-4960-991C-DDCD512621DE

P433

Q21131403-BCE2AF80-A48F-41F7-8856-09A4442DB954

P478

Q21131403-89C6226C-5490-4B8A-B14F-B10A3E1CB0D4

P50

Q21131403-2F26F288-45B8-4BF5-888A-7A631516C23A

Q21131403-58400558-B461-45A3-A450-49CF6A841644

Q21131403-92A096C9-43DB-48EF-A3DB-B8EF50DCD197

Q21131403-E16C3642-484B-4FED-A5D2-F7A6625FB035

P5008

Q21131403-466006CD-188B-4CFC-BF36-DBF8601C5E59

P577

Q21131403-6073724A-1346-45F4-9A89-4C0B0DA163A5

P5875

Q21131403-F2DFEDB7-FF8F-476F-A14D-E49E141891C0

P698

Q21131403-34EECD30-E77D-4835-A6A2-B412268C9754

P921

Q21131403-181F4B64-199A-4A22-BC0B-740B3D9B49F1

Q21131403-42DD076E-1645-4D24-9C34-C3BAACAB3598

Q21131403-5EBA9AAC-B16A-461F-9E29-6321F0E7DC2C

P932

Q21131403-F4730219-75B6-4119-8382-773561DE3AAB

P3181

P356

JOURNAL.PPAT.1002464

P1433

P1476

Tuberculosis and HIV co-infection

@en

P2093

Markus Sköld

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis

T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice

Reactivation of latent tuberculosis in cynomolgus macaques infected with SIV is associated with early peripheral T cell depletion and not virus load

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis

HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes

Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice

Mycobacteria target DC-SIGN to suppress dendritic cell function

P304

e1002464

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

182635

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PPAT.1002464

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Andrzej Pawlowski

Gunilla Källenius

Martin E Rottenberg

Marianne Jansson

P5008

P577

2012-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221859497

http://www.w3.org/2001/XMLSchema#string

P698

22363214

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

human immunodeficiency virus infectious disease

P932

3280977

http://www.w3.org/2001/XMLSchema#string